pfizer featured image
News Pharmaceutical & Biotech Stories

Pfizer to seek FDA Approval for COVID Vaccine in November

Pfizer will seek emergency US approval for the coronavirus vaccine in the third week of November.

Pfizer’s Chief Executive, Albert Bourla said in an open letter that he wanted to “provide greater clarity around the development timelines” of the vaccine, which is being tested on some 38,000 people worldwide.”

Bourla also added that Pfizer could know whether the vaccine was effective by the end of October. 

The FDA requires at least two months of safety data on half of the trial participants to grant emergency approval, he said, as well as information on the effectiveness and proof it can be manufactured safely.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS

Send this to a friend